Basilea Pharmaceutica Ltd. Logo
 

Dermatology 2007

 
 
 

Alitretinoin

  • Schäfer C. Chronic hand eczema: New application area for alitretinoin. Dtsch Apoth Ztg. 2007; 147(48): 37-38.
  • Scheinfeld N, Michaels J. Alitretinoin. Retinoid treatment of chronic hand dermatitis. Drugs Future 2007; 32(11): 943-951.

 

European Dermatology Review. Emerging treatment strategies for severe, chronic hand eczema. Reviewed by Diepgen ThL. 2007

16th Congress of the European Academy of Dermatology and Venereology EADV, May 2007, Vienna, Austria

  • P-275 / Efficacy and safety of alitretinoin in severe refractory chronic hand eczema. Ruzicka T, Gupta A, Jemec G, Gerlach B, Maares J, Wevelsiep L.
  • P-280 / Re-treatment study of alitretinoin (9-cis retinoic acid) in severe chronic hand eczema refractory to topical treatment. Ruzicka T, Lahfa M, Lynde Ch, Coenraads PJ, Harsch M, Maares J.
  • P-281 / An open label study of the safety and efficacy of alitretinoin in severe refractory chronic hand eczema. Diepgen T, Maleszka R, Bissonnette R, Augustin M, Harsch M, Brown T.
  • P-286 / Alitretinoin (BAL4079; 9-cis retinoic acid): Pharmacokinetic interactions between aitretinoin, ketoconazole, simvastatin and cyclosporine A. Schmitt-Hoffmann A, Roos B, Baumgaertner E, Maares J.
  • P-287 / Alitretinoin (BAL4079; 9-cis retinoic acid): Pharmacokinetics after single and repeated oral dosing of 20 and 40mg in healthy volunteers. Schmitt-Hoffman A, Roos B, Brown T, Meyer I.
  • P-288 / Alitretinoin (BAL4079; 9-cis retinoic acid): Pharmacokinetics after single and repeated oral dosing of 5, 10 and 20mg in healthy volunteers. Schmitt-Hoffman A, Roos B, Brown T, Maares J.
  • P-289 / Alitretinoin (BAL4079; 9-cis retinoic acid): Mass-balance excretion study of oral alitretinoin in healthy volunteers. Schmitt-Hoffman A, Roos B, Brown T, van Lier JJ.
  • P-290 / Alitretinoin (BAL4079: 9-cis retinoic acid): Low levels in seminal fluid after repeated oral dosing. Schmitt-Hoffman A, Roos B, Brown T, Meyer I.
 
Info